The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Pharm Biol. 2023 Dec;61(1):80-88. doi: 10.1080/13880209.2022.2157842.
Qingluotongbi formula (QLT) is a Chinese medicine compound consisting of Hook. f. (Celastraceae, TW), (Burkill) F.H.Chen (Araliaceae, PN), (Gaertn.) DC. (Orobanchaceae, RG), (Thunb.) Rehder & E.H. Wilson (Menispermaceae, SA), and L. (Bombycidae, BM).
This study investigated the protective effect and possible mechanism of QLT against TW-induced liver injury in mice.
To establish the model of TW-induced liver injury in mice, C57BL/6J mice were randomly divided into 4 groups: control group, low-dose TW group, middle-dose TW group, and high-dose TW group. To observe the effects of QLT and its individual ingredients against TW-induced liver injury, C57BL/6J mice were randomly divided into 7 groups: control group, TW group, QLT group, PN group, RG group, SA group, BM group.After administration for 7 days, C57BL/6J mice were tested for biochemical indicators and liver pathological changes. Then, we evaluated the mitochondrial function and analysed the gene and protein expression related to the peroxisome proliferator-activated receptor alpha (PPARα)/peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) pathway by quantitative real-time PCR (qRT-PCR) and Western blotting.
Compared with the control group (0.30 ± 0.35), TW significantly increased mice liver histological score (L, 0.95 ± 1.14; M, 1.25 ± 1.16; H, 4.00 ± 1.13). QLT and its ingredients significantly improved the pathology scores (CON, 0.63 ± 0.74; TW, 4.19 ± 1.53; QLT, 1.56 ± 0.62; PN, 1.94 ± 0.68; RG, 2.75 ± 1.39; SA, 4.13 ± 0.99; BM, 4.13 ± 0.99). Western blot and qRT-PCR analysis revealed that QLT and its ingredients reversed TW-induced suppression of PPARα/PGC1-α pathway.Discussion and conclusions: These findings provide valuable information for compound compatibility studies and TW clinical applications.
青藤碱配方(QLT)是一种中药复方,由钩藤(Celastraceae,TW)、两面针(Burkill)F.H.Chen(Araliaceae,PN)、徐长卿(Gaertn.)DC.(Orobanchaceae,RG)、鸡血藤(Thunb.)Rehder & E.H. Wilson(Menispermaceae,SA)和甘草(L.)(Bombycidae,BM)组成。
本研究旨在探讨 QLT 对 TW 诱导的小鼠肝损伤的保护作用及其可能机制。
为建立 TW 诱导的小鼠肝损伤模型,将 C57BL/6J 小鼠随机分为 4 组:对照组、低剂量 TW 组、中剂量 TW 组和高剂量 TW 组。为观察 QLT 及其单体成分对 TW 诱导的肝损伤的影响,将 C57BL/6J 小鼠随机分为 7 组:对照组、TW 组、QLT 组、PN 组、RG 组、SA 组、BM 组。给药 7 天后,检测 C57BL/6J 小鼠的生化指标和肝组织病理学变化。然后,通过实时定量 PCR(qRT-PCR)和 Western blot 评估线粒体功能,并分析与过氧化物酶体增殖物激活受体α(PPARα)/过氧化物酶体增殖物激活受体γ共激活因子 1α(PGC-1α)通路相关的基因和蛋白表达。
与对照组(0.30±0.35)相比,TW 显著增加了小鼠肝组织学评分(L,0.95±1.14;M,1.25±1.16;H,4.00±1.13)。QLT 及其成分显著改善了病理评分(CON,0.63±0.74;TW,4.19±1.53;QLT,1.56±0.62;PN,1.94±0.68;RG,2.75±1.39;SA,4.13±0.99;BM,4.13±0.99)。Western blot 和 qRT-PCR 分析显示,QLT 及其成分逆转了 TW 诱导的 PPARα/PGC1-α 通路抑制。
这些发现为复方配伍研究和 TW 的临床应用提供了有价值的信息。